Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

This study has been terminated.
(lack of patients who meet inclusion criteria)
Sponsor:
Collaborators:
Duke University
Eli Lilly and Company
Information provided by (Responsible Party):
Mark Feinglos, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01326117
First received: March 29, 2011
Last updated: December 5, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)